Search by Drug Name or NDC

    NDC 50419-0395-72 NUBEQA 300 mg/1 Details

    NUBEQA 300 mg/1

    NUBEQA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer HealthCare Pharmaceuticals Inc.. The primary component is DAROLUTAMIDE.

    Product Information

    NDC 50419-0395
    Product ID 50419-395_78565601-df32-45a6-9d08-ac84738c8963
    Associated GPIs 21402425000320
    GCN Sequence Number 080069
    GCN Sequence Number Description darolutamide TABLET 300 MG ORAL
    HIC3 V1J
    HIC3 Description ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
    GCN 46746
    HICL Sequence Number 045909
    HICL Sequence Number Description DAROLUTAMIDE
    Brand/Generic Brand
    Proprietary Name NUBEQA
    Proprietary Name Suffix n/a
    Non-Proprietary Name darolutamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name DAROLUTAMIDE
    Labeler Name Bayer HealthCare Pharmaceuticals Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212099
    Listing Certified Through 2024-12-31

    Package

    NDC 50419-0395-72 (50419039572)

    NDC Package Code 50419-395-72
    Billing NDC 50419039572
    Package 1 BOTTLE in 1 CARTON (50419-395-72) / 120 TABLET, FILM COATED in 1 BOTTLE
    Marketing Start Date 2021-03-03
    NDC Exclude Flag N
    Pricing Information N/A